GlassScriptPhysician profile
Mai Pham
NPI 1558850990
$6,602.52
in general payments reported to CMS, 2019-2025
23 companies · $3,718 in 2025
The $3,718 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $226 · 2022: $822 · 2023: $1,444 · 2024: $392 · 2025: $3,718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,511 · Travel and Lodging: $2,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,511.49 |
| Travel and Lodging | $2,043.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,299.89 | 2023-2025 | Prostep, Hoffmann, Flexband |
| Treace Medical Concepts, INC. | $979.05 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $824.53 | 2021-2025 | Nuzyra |
| Horizon Therapeutics Plc | $628.63 | 2022-2023 | Krystexxa |
| Smith+Nephew, INC. | $327.05 | 2021-2024 | Collagenase Santyl, Regranex, Renasys Go V2 Home |
| Biotissue Holdings INC. | $256.36 | 2021-2023 | |
| Abbvie INC. | $180.96 | 2023-2025 | |
| Medline Industries LP | $161.12 | 2025 | |
| Amgen INC. | $158.47 | 2024-2025 | Krystexxa |
| Keystone Dental INC. | $151.58 | 2022 | |
| Arcutis Biotherapeutics, INC. | $124.40 | 2025 | Zoryve |
| Urgo Medical North America, LLC | $113.27 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Ibsa Pharma INC. | $99.51 | 2021-2024 | Tirosint, Licart, Licart |
| Nevro Corp. | $90.60 | 2022-2023 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $40.07 | 2022-2024 | Cabtreo |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $31.84 | 2022 | |
| Averitas Pharma INC. | $30.38 | 2025 | Qutenza |
| Nabriva Therapeutics, Plc | $26.89 | 2022 | |
| Kci USA, INC. | $20.96 | 2022 | |
| Reddress USA, INC. | $18.00 | 2025 | Actigraft |
| Organogenesis INC. | $17.52 | 2023 | Puraply |
| Reapplix INC. | $14.22 | 2021 | |
| Kerecis Limited | $7.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mai Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.